Collegium Submits Supplemental New Drug Submission to FDA for Xtampza® ER
Oct 05, 2016 11:06 am UTC| Business
CANTON, Mass., Oct. 05, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food Drug Administration (FDA) to enhance the...
Hunt Mining Announces Key Personnel for Martha Project Production
Oct 05, 2016 11:01 am UTC| Business
LIBERTY LAKE, Wash., Oct. 05, 2016 -- Hunt Mining Corp. ("Hunt" or the "Company") (TSXV:HMX) is pleased to announce two additions to the Company’s management team; both of whom formerly worked with Coeur Argentina at...
Oct 05, 2016 11:01 am UTC| Business
The Phase II clinical study is intended to evaluate the efficacy and safety of YELIVA™ (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), the most common primary malignant cancer of the liver with a...
Oct 05, 2016 11:01 am UTC| Business
The Phase II clinical study is intended to evaluate the efficacy and safety of YELIVA™ (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), the most common primary malignant cancer of the liver with a...
Eze Software Group Ranked Among Top 100 FinTech Companies
Oct 05, 2016 11:01 am UTC| Business
BOSTON, Oct. 05, 2016 -- Eze Software Group, a premier provider of global investment technology, has been ranked among the top 100 financial technology companies in two prestigious industry surveys. Eze was ranked #52...
Eze Software Group Ranked Among Top 100 FinTech Companies
Oct 05, 2016 11:01 am UTC| Business
BOSTON, Oct. 05, 2016 -- Eze Software Group, a premier provider of global investment technology, has been ranked among the top 100 financial technology companies in two prestigious industry surveys. Eze was ranked #52...
Oct 05, 2016 11:01 am UTC| Business
NEW YORK, Oct. 05, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight